Table 1 Change in post-volume pre-COVID-19 and COVID-19 periods among leading substances discussed on opioid-related forums
Pre-COVID-19 period daily average | COVID-19 period daily average | Difference | Change (%) | |
|---|---|---|---|---|
Medications for Opioid Use Disorder and Overdose Reversal | ||||
Methadone | 20.751 | 56.313 | 35.562 | 171.4% |
Naltrexone | 1.087 | 2.451 | 1.364 | 125.5% |
Buprenorphine | 18.426 | 36.225 | 17.800 | 96.6% |
Naloxone | 1.680 | 3.116 | 1.436 | 85.5% |
Other Substances used in Non-Medical Settings | ||||
Iboga | 0.520 | 1.175 | 0.655 | 125.9% |
Kratom | 3.454 | 7.222 | 3.768 | 109.1% |
Prescription and Illegal Opioids | ||||
Hydrocodone | 0.986 | 2.687 | 1.701 | 172.6% |
Fentanyl | 9.506 | 25.404 | 15.898 | 167.2% |
Oxycodone | 2.191 | 5.796 | 3.606 | 164.6% |
Other prescription opioids | 1.605 | 3.687 | 2.083 | 129.8% |
Heroin | 8.325 | 14.677 | 6.352 | 76.3% |
Carfentanil | 0.325 | 0.411 | 0.086 | 26.5% |
Other Medications | ||||
Diphenhydraminea | 0.341 | 0.927 | 0.586 | 171.8% |
Diazepam | 0.504 | 1.324 | 0.820 | 162.9% |
Other benzodiazepines | 4.791 | 11.178 | 6.388 | 133.3% |
Alprazolam | 1.384 | 3.164 | 1.780 | 128.7% |
Dextromethorphana | 0.146 | 0.291 | 0.145 | 99.4% |
Dextroamphetamine | 1.252 | 2.131 | 0.879 | 70.2% |